This HTML5 document contains 133 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n9http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q43865313
rdf:type
wikibase:Item
schema:description
article scientifique artigo científico artículu científicu espublizáu en 2002 מאמר מדעי artikel ilmiah vědecký článek 2002年学术文章 artikull shkencor vitenskapelig artikkel artykuł naukowy ফেব্রুয়ারি ২০০২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2002年學術文章 2002年學術文章 article científic artigo científico სამეცნიერო სტატია 2002年学术文章 2002 nî lūn-bûn teaduslik artikkel επιστημονικό άρθρο vitskapeleg artikkel tieteellinen artikkeli научна статия wetenschappelijk artikel naučni članak научни чланак 2002年学术文章 artikulong pang-agham article scientific บทความทางวิทยาศาสตร์ 2002年學術文章 2002年学术文章 2002年の論文 2002年學術文章 мақолаи илмӣ articolo scientifico scientific article published in February 2002 2002년 논문 scientific article published in February 2002 artículo científico publicado en 2002 bilimsel makale научная статья 2002年學術文章 vedecký článok наукова стаття, опублікована в лютому 2002 2002年学术文章 bài báo khoa học artigo científico scientific article published in February 2002 vetenskaplig artikel 2002年学术文章 научни чланак articol științific wissenschaftlicher Artikel videnskabelig artikel tudományos cikk مقالة علمية نشرت في فبراير 2002 scienca artikolo
p:P577
wds:Q43865313-789AF962-C57F-44E3-9AB0-E44854C8C4F4
wdt:P577
2002-02-01T00:00:00Z
p:P407
wds:Q43865313-07B0346A-1A01-4614-92EC-1D3980DF12CA
wdt:P407
wd:Q1860
p:P2860
wds:Q43865313-19600E6D-5175-4349-8CE8-D40F578E2DEB wds:Q43865313-1A5C0179-110D-42A0-BB59-CF987D25E727 wds:Q43865313-446A83EF-F41D-4B70-B117-7EB421EB0C3B wds:Q43865313-459E442A-1ABA-411B-9709-325C0A62EDF6 wds:Q43865313-593D27CF-886F-4819-BDCA-FAB251F2EF2A wds:Q43865313-5D03B2C7-9148-4E1F-93EA-C9CE7914C72F wds:Q43865313-627DFB8A-919C-4654-B6FF-ECB21016C9B6 wds:Q43865313-6C9288BE-DB10-4354-8CCA-D33506808672 wds:Q43865313-82B65922-02A5-44B4-A7BD-13FCA7C3F495 wds:Q43865313-A3F7E6BF-AC9B-48E5-B26A-7E20134E4148 wds:Q43865313-A61379FE-3ABB-493F-9370-34F8F97BEF5E wds:Q43865313-C2EE6836-BFEC-43A3-878A-E35D190B2FE5 wds:Q43865313-C3ED99D7-C7B2-4133-B86B-A8CD01F4B5B6 wds:Q43865313-03143858-775F-4A62-B651-496FB46D1FC7
wdt:P2860
wd:Q36856232 wd:Q28245573 wd:Q70633267 wd:Q54136935 wd:Q28379241 wd:Q42543469 wd:Q73193141 wd:Q46040906 wd:Q74780017 wd:Q73944461 wd:Q71020151 wd:Q73456991 wd:Q73857145 wd:Q70555895
p:P2093
wds:Q43865313-D3C641A5-DE9E-4BCD-8933-CE87EA73160B wds:Q43865313-0CB8C89B-3D10-4AB4-89B5-4C41FF10F3D3 wds:Q43865313-0488F54D-3CE8-4DE8-9447-60676367352C wds:Q43865313-4C1E6E61-16C0-4AE9-8198-BCA65EA4629F wds:Q43865313-48474424-EEA5-4DB6-9F2E-0FAC7091D1BF wds:Q43865313-39ABC049-7718-4FFE-922B-F621AD110782 wds:Q43865313-346D6B47-DC82-4DCD-B018-A12E6940075C
wdt:P2093
Kiyoshi Yoshida Atsushi Yamamuro Shigefumi Morioka Takashi Akasaka Koichi Tamita Kenji Yamabe Tsutomu Takagi
rdfs:label
Impact of troglitazone on coronary stent implantation using small stents in patients with type 2 diabetes mellitus Impact of troglitazone on coronary stent implantation using small stents in patients with type 2 diabetes mellitus
skos:prefLabel
Impact of troglitazone on coronary stent implantation using small stents in patients with type 2 diabetes mellitus Impact of troglitazone on coronary stent implantation using small stents in patients with type 2 diabetes mellitus
schema:name
Impact of troglitazone on coronary stent implantation using small stents in patients with type 2 diabetes mellitus Impact of troglitazone on coronary stent implantation using small stents in patients with type 2 diabetes mellitus
p:P50
wds:Q43865313-91D14C0D-CEE1-447E-9FF9-B03E80153E37
wdt:P50
wd:Q42410155
p:P1476
wds:Q43865313-E6CEB0E5-9B3F-4910-B8CF-B4D31DD4F6E3
wdt:P1476
Impact of troglitazone on coronary stent implantation using small stents in patients with type 2 diabetes mellitus
p:P304
wds:Q43865313-238EB6BC-5E69-4318-9C55-E90D9A19124C
wdt:P304
318-322
p:P31
wds:Q43865313-376C5DDF-B49F-4B0F-8979-63E87B4C597F
wdt:P31
wd:Q13442814
p:P921
wds:Q43865313-05727C74-4BB4-4119-B639-4F6D5D46B401
wdt:P921
wd:Q3025883
p:P698
wds:Q43865313-668B81A4-FC0E-44EB-A55E-073B42B56DFD
wdtn:P698
n12:11809434
wdt:P698
11809434
p:P1433
wds:Q43865313-779D37BE-43CB-4A96-859B-1EC41DA6112D
wdt:P1433
wd:Q2208417
p:P433
wds:Q43865313-E677A789-62C1-42DF-81BE-200376686FFD
p:P478
wds:Q43865313-DE25A169-7235-4456-BF59-EE5E84D430B2
wdt:P433
3
wdt:P478
89
p:P356
wds:Q43865313-59CFE097-A395-4015-9DFE-637139E4CFA6
wdtn:P356
n9:S0002-9149(01)02232-9
wdt:P356
10.1016/S0002-9149(01)02232-9